Department of Medicine, Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
PLoS One. 2021 May 14;16(5):e0251308. doi: 10.1371/journal.pone.0251308. eCollection 2021.
Increased oxidative stress, leukocyte telomere length (LTL) shortening, endothelial dysfunction, and lower insulin-like growth factor (IGF)-1 concentrations reflect key molecular mechanisms of aging. We hypothesized that biomarkers representing these pathways are associated with measures of subclinical atherosclerosis and all-cause mortality.
We evaluated up to 2,314 Framingham Offspring Study participants (mean age 61 years, 55% women) with available biomarkers of aging: LTL, circulating concentrations of IGF-1, asymmetrical dimethylarginine (ADMA), and urinary F2-Isoprostanes indexed to urinary creatinine. We evaluated the association of each biomarker with coronary artery calcium [ln (CAC+1)] and carotid intima-media thickness (IMT). In multivariable-adjusted linear regression models, higher ADMA levels were associated with higher CAC values (βADMA per 1-SD increase 0.25; 95% confidence interval [CI] [0.11, 0.39]). Additionally, shorter LTL and lower IGF-1 values were associated with higher IMT values (βLTL -0.08, 95%CI -0.14, -0.02, and βIGF-1 -0.04, 95%CI -0.08, -0.01, respectively). During a median follow-up of 15.5 years, 593 subjects died. In multivariable-adjusted Cox regression models, LTL and IGF-1 values were inversely associated with all-cause mortality (hazard ratios [HR] per SD increase in biomarker, 0.85, 95% CI 0.74-0.99, and 0.90, 95% CI 0.82-0.98 for LTL and IGF-1, respectively). F2-Isoprostanes and ADMA values were positively associated with all-cause mortality (HR per SD increase in biomarker, 1.15, 95% CI, 1.10-1.22, and 1.10, 95% CI, 1.02-1.20, respectively).
In our prospective community-based study, aging-related biomarkers were associated with measures of subclinical atherosclerosis cross-sectionally and with all-cause mortality prospectively, supporting the concept that these biomarkers may reflect the aging process in community-dwelling adults.
氧化应激增加、白细胞端粒长度(LTL)缩短、内皮功能障碍和胰岛素样生长因子(IGF)-1 浓度降低反映了衰老的关键分子机制。我们假设代表这些途径的生物标志物与亚临床动脉粥样硬化和全因死亡率的测量值相关。
我们评估了多达 2314 名弗雷明汉后代研究参与者(平均年龄 61 岁,55%为女性)的衰老生物标志物:LTL、循环 IGF-1 浓度、不对称二甲基精氨酸(ADMA)和尿 F2-异前列腺素,均以尿肌酐为指标。我们评估了每个生物标志物与冠状动脉钙[ln(CAC+1)]和颈动脉内膜-中层厚度(IMT)的相关性。在多变量调整后的线性回归模型中,较高的 ADMA 水平与较高的 CAC 值相关(βADMA 每增加 1-SD 增加 0.25;95%置信区间[CI] [0.11,0.39])。此外,较短的 LTL 和较低的 IGF-1 值与较高的 IMT 值相关(βLTL -0.08,95%CI -0.14,-0.02,和βIGF-1 -0.04,95%CI -0.08,-0.01,分别)。在中位数为 15.5 年的随访期间,593 名受试者死亡。在多变量调整后的 Cox 回归模型中,LTL 和 IGF-1 值与全因死亡率呈负相关(生物标志物每增加 1-SD 的风险比[HR],0.85,95%CI 0.74-0.99,和 0.90,95%CI 0.82-0.98 分别用于 LTL 和 IGF-1)。F2-异前列腺素和 ADMA 值与全因死亡率呈正相关(生物标志物每增加 1-SD 的 HR,1.15,95%CI,1.10-1.22,和 1.10,95%CI,1.02-1.20,分别)。
在我们的前瞻性社区研究中,与衰老相关的生物标志物与亚临床动脉粥样硬化的横断面测量值以及全因死亡率的前瞻性测量值相关,支持这些生物标志物可能反映社区成年人衰老过程的概念。